Tren Is Literally Birth Control Inside Your Brain

Trenbolone binds the same brain receptor that the progestins in a birth control pill bind. Your estradiol reads normal. Every marker your doctor checks comes back fine. In 1972, an earlier ester of trenbolone sat on a French pharmacy shelf as a legal prescription drug sold to human patients. The approval was built on a few dozen rats. This is the full record, and the pharmacology underneath it. ━━━━━━━━━━━━━━━━━━━━ WORK WITH ME Coaching https://kahunas.io/contact/person_inf... Book a consult call https://molecularcoaching.com/appoint... ApoB calculator https://molecularcoaching.com/calculator ━━━━━━━━━━━━━━━━━━━━ WHAT'S COVERED Hexabolan from 1972, and Parabolan from 1980 to 1997, both sold to human patients in France The veterinary version that went through a complete FDA trial package in 1987, while the human version never had one Why trenbolone functions as an aromatase inhibitor Why gyno still happens anyway, through the progesterone receptor What it does to the brain, and why bloodwork misses all of it ━━━━━━━━━━━━━━━━━━━━ CHAPTERS 0:00 The receptor nobody checks 0:45 PART 1 - The Forgotten Human Approval 5:14 The rat approval dossier 34:18 The molecule and its sister compound 42:52 What "prescribed" actually meant 46:59 The 1972 launch 50:54 The Vidal 1975 Hexabolan monograph 58:36 The Negma years, 1973-1989 1:03:12 The Vidal 1996 Parabolan monograph 1:14:47 The 1997 dual-track moment 1:19:36 The Finaplix veterinary parallel 1:31:47 Modern persistence 1:42:00 Synthesis - what the record does and doesn't show 1:43:44 PART 2 - Tren Is Functionally an Aromatase Inhibitor 1:45:02 What an aromatase inhibitor does 1:45:40 No additional substrate 1:46:54 The indirect AI - adipose aromatase suppression 1:54:54 Coactivator squelching 2:09:48 PART 3 - Why Tren Gyno Happens Anyway 2:11:04 The backup aromatase promoter in breast fat 2:13:08 Not enough androgen receptor to win the competition 2:14:04 Trenbolone as a supraphysiological PR agonist 2:16:06 What PR does to the estrogen system 2:18:56 How they combine, and why the standard toolkit fails 2:19:57 Beyond breast tissue 2:22:12 PART 4 - Why Tren Breaks the Brain 2:23:37 The epidemiology 2:28:07 Progesterone receptor, allopregnanolone, GABA-A 2:39:05 Direct CNS insult - barrier, synapses, NMDA, myelin 2:58:02 Human imaging - the amygdala findings 3:00:47 Behavioral disinhibition and the attraction-shift question 3:09:20 Structural persistence - the INSL3 finding 3:12:23 Synthesis and the protective stack 3:21:18 What this doesn't prove 3:23:53 Acknowledgements ━━━━━━━━━━━━━━━━━━━━ SOURCES & RESOURCES 146 sources. Primary documents throughout: the patents, the French Brevet Spécial de Médicament filings, the Vidal monographs, the Negma prescribing insert, FDA NADA 138-612, and the case-report archive. Full citation list (PDF) https://molecularcoaching.com/citatio... Dr Jean-Pierre de Mondenard's archive https://dopagedemondenard.com/ Many of the primary sources are under copyright and I can't republish the full documents, but the citation list gives you everything you need to find them. ━━━━━━━━━━━━━━━━━━━━ ACKNOWLEDGEMENTS Jean-Pierre de Mondenard opened his archive to me. The Fiche Trénbolone, the case reports, the letter from the French drug information bureau, collected across decades of work nobody else was doing. FurionPharm co-authored this. Coactivator squelching and the I.4 promoter both came from him. Vigorous Steve sent me the Negma insert, the leaflet that came folded inside the box. Mike chased the French government records. TaxMachine, Andrew, and Professor Parabolan argued the ideas out with me in Discord. ━━━━━━━━━━━━━━━━━━━━ DISCLAIMER This is a documentary about pharmacology and regulatory history. It is not medical advice, and it is not an endorsement of using any of these compounds. #trenbolone #steroids #pharmacology #endocrinology #bodybuilding